FOLH1 and cancer: A potential route by which cancer cells can overcome proteasome inhibition is by invoking the NRF1-mediated bounce-back response to transcriptionally upregulate PSM genes, resulting in de novo proteasome synthesis and a subsequent rescue of proteasome activity18, 19.